Skip to main content

Table 1 Clinical characteristics of ALL patients

From: Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding

Parameters

ALL (n = 101)

Gender

 

 Male

54 (53.5%)

 Female

47 (46.5%)

Mean age (years, range)

7.2 (0-17)

Initial WBC (× 10 9 /L)

 

 <20

63 (62.4%)

 20- < 100

26 (25.7%)

 ≥100

12 (11.9%)

Immunophenotype

 

 pro-B-ALL

3 (3%)

 pre-B-ALL

18 (17.8%)

 common-ALL

63 (62.4%)

 mature B-ALL

3 (3%)

 T-ALL

14 (13.8%)

FAB

 

 L1

65 (64.4%)

 L1/L2

5 (4.9%)

 L2

28 (27.7%)

 L3

3 (3%)